European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Providing the New Generation of Nano-Based Molecular Technology for the Early Detection of Bacteria, Viruses and Cancer at the Point of Care

Objectif

There is a need for cost-effective molecular point of care diagnostic tools to provide better healthcare to patients and better agility to our healthcare system. And what about going one step further by extending the limits of molecular diagnostics to the nano-scale?
We have developed the nano-technology-based solution nano4. nano4 is a fast and user-friendly nano-based diagnostic technology suitable for use at the POC. nano4 represents a highly specific and sensitive nanotechnology for in vitro molecular diagnostics. nano4 uses gold nano-probes to recognize the complementary DNA/RNA strand and yield a color output that allows for quick decision making.
Our ultimate objective is to leverage the diagnostic possibilities of nano-technology for all its applications in medicine and life science, thereby expanding the current possibilities of molecular analysis. We are convinced that the fast, accurate, low-cost and user-friendly diagnostic of certain viruses, pathogens and cancer-types through nano4 will help healthcare decision-makers to act quickly, thereby saving lives, pain, mistakes and even preventing epidemics. Our business objective is to make nano4 a standard POC diagnostics technology present at each POC globally and to become the global leader in nano-based molecular diagnostic technology.
Easily accessible fast molecular testing is a tremendous challenge especially when reliable results are needed quickly and cost-efficiently. Especially now, with the migrant crisis, cases of TB and Zika are more frequent. Each application of nano4 can answer a specific European challenge.
We will conduct several activities including production process analysis, cost-benefit analysis, partner search, market research, customer validation activities, price acceptance analysis, focus groups, surveys and strategic planning, risk and regulatory environment assessment, as well as document drafting.

Appel à propositions

H2020-SMEInst-2016-2017

Voir d’autres projets de cet appel

Sous appel

H2020-SMEINST-1-2016-2017

Régime de financement

SME-1 - SME instrument phase 1

Coordinateur

NANO4 GLOBAL LDA
Contribution nette de l'UE
€ 50 000,00
Adresse
Estrada da Granja do Marquês, nº 339, Armazém B
2710-142 Sintra
Portugal

Voir sur la carte

PME

L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.

Oui
Région
Continente Área Metropolitana de Lisboa Área Metropolitana de Lisboa
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
€ 71 429,00